3D‐QSAR, molecular docking, molecular dynamics, and ADME/T analysis of marketed and newly designed flavonoids as inhibitors of Bcl‐2 family proteins for targeting U‐87 glioblastoma. Issue 2 (17th November 2021)

• Record Type: Journal Article
• Authors: Poustforoosh, Alireza; Faramarz, Sanaz; Nematollahi, Mohammad Hadi; Hashemipour, Hassan; Tüzün, Burak; Pardakhty, Abbas; Mehrabani, Mehrnaz
• Is Part Of: Journal of cellular biochemistry. Volume 123:Issue 2(2022)
• Page Start: 390
• Page End: 405
• Publication Date: 2021-11-17
• Subjects: 3D‐QSAR -- Bcl‐2 family proteins -- flavonoids -- glioblastoma -- molecular dynamics; Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.30178
• Languages: English
• ISSNs: 0730-2312

Abstract

Abstract: Glioblastoma is the most common and destructive brain tumor with increasing complexity. Flavonoids are versatile natural compounds with the approved anticancer activity, which could be considered as a potential treatment for glioblastoma. A quantitative structure‐activity relationship (QSAR) can provide adequate data for understanding the role of flavonoids structure against glioblastoma. The IC50 of various flavonoids for the U‐87 cell line was used to prepare an adequate three‐dimensional QSAR (3D‐QSAR) model. The validation of the model was carried out using some statistical parameters such as R 2 and Q 2 . Based on the QSAR model, the activities of other marketed and newly designed flavonoids were predicted. Molecular docking study and molecular dynamics (MD) simulation were conducted for better recognition of the interactions between the most active compounds and Bcl‐2 family proteins. Moreover, an AMDE/T analysis was performed for the most active flavonoids. A reliable 3D‐QSAR was performed with R 2 and Q 2 of 0.91 and 0.82. The molecular docking study revealed that BCL‐XL has a higher binding affinity with the most active compounds, and the MD simulation showed that some residues of the BH3 domain, such as Phe97, Tyr101, Arg102, and Phe105 create remarkable hydrophobic interactions with the ligands. ADME/T analysis also showed the potential of the active compounds for further investigation. 3D‐QSAR study is a beneficial method to evaluate and design anticancer compounds. Considering the results of the molecular docking study, MD simulation, and ADME/T analysis, the designed compound 54 could be considered as a potential treatment for glioblastoma.